Replies to post #2667 on Nascent Biotech Inc. (NBIO)

[BlazingStocks]

Agreed a HUGE step forward...plus we should be getting News on Phase I results soon.

Data related to Phase 1 Clinical Research evaluating safety and tolerance for PTB as a treatment for Primary and Metastatic Brain Cancers has also been submitted to the FDA. The Company anticipates initial comments from the FDA approximately 30 days from the date of filing.

$NBIO